Technical Analysis for NTBL - Notable Labs, Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | -1.92% | |
| Calm After Storm | Range Contraction | -1.92% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| 20 DMA Resistance | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| Up 5% | 1 day ago |
Get a Trading Assistant
- Earnings date: 05/13/2024
Notable Labs, Ltd. Description
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Treatment Acute Myeloid Leukemia Orphan Drug Protein Kinase Inhibitor Myelodysplastic Syndrome Chronic Myeloid Leukemia Kinase 1 Lintuzumab
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.2 |
| 52 Week Low | 0.833 |
| Average Volume | 466,530 |
| 200-Day Moving Average | 3.53 |
| 50-Day Moving Average | 1.32 |
| 20-Day Moving Average | 1.05 |
| 10-Day Moving Average | 1.14 |
| Average True Range | 0.17 |
| RSI (14) | 43.50 |
| ADX | 30.4 |
| +DI | 28.44 |
| -DI | 17.56 |
| Chandelier Exit (Long, 3 ATRs) | 1.33 |
| Chandelier Exit (Short, 3 ATRs) | 1.37 |
| Upper Bollinger Bands | 1.32 |
| Lower Bollinger Band | 0.77 |
| Percent B (%b) | 0.45 |
| BandWidth | 52.65 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.0157 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.23 | ||||
| Resistance 3 (R3) | 1.25 | 1.20 | 1.20 | ||
| Resistance 2 (R2) | 1.20 | 1.15 | 1.19 | 1.18 | |
| Resistance 1 (R1) | 1.11 | 1.11 | 1.09 | 1.09 | 1.17 |
| Pivot Point | 1.06 | 1.06 | 1.05 | 1.05 | 1.06 |
| Support 1 (S1) | 0.97 | 1.01 | 0.95 | 0.95 | 0.87 |
| Support 2 (S2) | 0.92 | 0.97 | 0.91 | 0.86 | |
| Support 3 (S3) | 0.83 | 0.92 | 0.85 | ||
| Support 4 (S4) | 0.81 |
